Komori
Medipal Holdings (7459) · InitiativeRestated

Development of temperature-monitoring loggers and high-precision traceability through a capital and business alliance with 神栄

First written in FY2022-Q3. 1 of 2 entries say "Restated". Latest entry: FY2022.

2entries
1years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022-Q3 – FY20222022: 22022
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「株式会社メディセオ and 神栄's subsidiary, 神栄テクノロジー株式会社 (Chuo-ku, Kobe), are jointly developing a logger for temperature-controlled management of pharmaceuticals for medical use and other products. Going forward, we will further expand its functionality to achieve highly accurate traceability from pharmaceutical companies through to patients.」

    We continue to pursue the joint development of temperature-control loggers with 神栄 under our capital and business alliance, along with functional expansion to cover humidity, shock, vibration and illuminance, and the establishment of highly accurate traceability.
  2. FY2022-Q3First statedAnnual report

    「In December of the same year, the Company subscribed to a third-party allocation of shares by 神栄株式会社 (Chuo-ku, Kobe; hereinafter, “神栄”), which operates businesses across a broad range of fields, including food, commodities, textiles and electronics, and entered into a capital and business alliance. メディセオ and 神栄テクノロジー株式会社, a subsidiary of 神栄 (Chuo-ku, Kobe), were jointly developing loggers for temperature control of prescription pharmaceuticals and other products. Going forward, the companies will expand the logger’s functions to measure humidity, shock, vibration and illuminance in addition to temperature, and work to achieve high-precision traceability from pharmaceutical companies to patients.」

    The Company subscribed to a third-party allocation of shares by 神栄 and entered into a capital and business alliance. メディセオ and 神栄テクノロジー will expand their joint development of pharmaceutical temperature-control loggers to include measurement of humidity, shock, vibration and illuminance, with the aim of achieving high-precision traceability.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medipal Holdings's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Development of temperature-monitoring loggers and high-precision traceability through a capital and business alliance with 神栄 | MEDIPAL HOLDINGS CORPORATION (7459) | Komori